The Smoke-free Environment and Regulated Products (Restrictions on Tobacco) Amendment Bill limits the number of retailers who are allowed to sell tobacco products, and prohibits the sale of these products to anyone born after 2009. The aim of the legislation is to reduce the appeal and addictive nature of tobacco products.
Nancy Loucas, co-founder of Aotearoa Vapers Community Advocacy (AVCA), recently expressed concern about the lack of enforcement in general convenience stores regarding the sale of electronic cigarettes, despite agreeing with the overall goal of the proposed bill. Some convenience store owners may prioritize sales to minors for profit over public interest. Loucas emphasized that new regulations are futile without consistent and effective enforcement. Some store owners may refuse to sell to minors, but others may not.
She added that the industry supports regulations to ensure minors cannot obtain the product and urges all electronic cigarette users and advocates for tobacco harm reduction to share their opinions and submit comments before the deadline of August 24th.
The submission period has now ended, and she hopes that local politicians will carefully review the submissions and take appropriate action. "We are heavily dependent on Members of Parliament reading and taking action on the valuable insights submitted to the Health Select Committee, which provide expert and practical solutions to help New Zealand achieve a smoke-free New Zealand by 2025," said Nancy Lucas.
The current direction of ASH is self-defeating, flawed, and harmful.
The documents submitted by Action for Smokefree Aotearoa 2025 (ASH) state that current restrictions on general retailers only selling tobacco, menthol and menthol flavoured closed e-cigarette systems are counterproductive, flawed, and harmful. "There is ample evidence to suggest that using fruit and other sweet flavoured e-liquids is positively associated with quitting smoking... International evidence from four countries concludes that users of sweet flavoured e-cigarettes are more likely to remain smoke-free by 1.6 times, while users of menthol-flavoured e-cigarettes are less likely to remain smoke-free," wrote ASH.
Dr. Marewa Glover, a tobacco control expert, has submitted materials stating that members of parliament should "reduce barriers to using e-cigarettes." "I am against the proposed new prohibition measures in the bill. There are more compassionate and cost-effective ways to reduce smoking rates. One of which is to encourage the use of lower risk alternatives... It has been found that using e-cigarettes is more effective than nicotine replacement therapy in helping people quit smoking," she said.
Statement:
This article is compiled based on third-party information for the purpose of industry exchange and learning.
This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity or accuracy of the article's content. The translation of this article is solely for the purpose of industry research and communication.
Due to limitations in translation abilities, the translated article may not accurately reflect the original text. Please refer to the original text for accuracy.
2FIRSTS aligns completely with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and positions.
The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us to request removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
